Insider Trading Stories

Acquisition by Avril Vicki L of tradable shares of SSgA subject to Rule 16b 3

 28 minutes ago at MacroaxisInsider 
Filed By Avril Vicki L, SSgA
Filed transaction by SSgA Officer Sr. V.p. And Cfo. Grant, award or other acquisition pursuant to Rule 16b-3. SSgA insider trading alert for acquisition of phantom stock by Avril Vicki L, Officer: Sr. V.p. And Cfo, on 25th of February 2025. This event was filed by SSgA with SEC on 2006-02-28. Statement of changes in beneficial ownership - SEC Form 4 [Continue Reading...]
null Ssga
Filed transaction by Si Bone Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 1619 common stock at 16.7706 of Si Bone by Jeffrey Dunn on 18th of February 2025. This event was filed by Si Bone with SEC on 2025-02-18. Statement of changes in beneficial ownership - SEC Form 4  
Si Bone
  54 minutes ago at Macroaxis
Filed for Jeffrey Dunn
Filed transaction by NOVA VISION ACQUISITION 10 Percent Owner. Discretionary transaction in accordance with Rule 16b-3(f). Transaction of 9000 redeemable warrants at 11.5 of NOVA VISION by Barclays Plc on 25th of February 2025. This event was filed by NOVA VISION ACQUISITION with SEC on 2028-12-31. Initial filing of beneficial ownership - SEC Form 3  
NOVA VISION ACQUISITION
  59 minutes ago at Macroaxis
Filed for Barclays Plc
Filed transaction by MILLROSE PROPERTIES INC 10 Percent Owner. Insider Public Trading. MILLROSE insider trading alert for general transaction of class a common stock, par value $0.01 per share by Lennar Corp /new/, 10 Percent Owner, on 7th of February 2025. This event was filed by MILLROSE PROPERTIES INC with SEC on 2025-02-07. Initial filing of beneficial ownership - SEC Form 3  
MILLROSE PROPERTIES INC
  few hours ago at Macroaxis
Filed for Lennar Corp /new/
Filed transaction by Vicarious Surgical Director, 10 Percent Owner, Officer: Chief Technology Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(.... Disposition of 754 class a common stock at 14.5305 of Vicarious Surgical by Sammy Khalifa on 20th of February 2025. This event was filed by Vicarious Surgical with SEC on 2025-02-20. Statement of changes in beneficial ownership - SEC Form 4  
Vicarious Surgical
  few hours ago at Macroaxis
Filed for Sammy Khalifa
Filed transaction by Hawthorn Bancshares Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 116 common stock at 32.9 of Hawthorn Bancshares by Holtaway Jonathan on 11th of February 2025. This event was filed by Hawthorn Bancshares with SEC on 2025-02-11. Statement of changes in beneficial ownership - SEC Form 4  
Hawthorn Bancshares
  few hours ago at Macroaxis
Filed for Holtaway Jonathan
Filed transaction by Hawthorn Bancshares Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 839 common stock at 32.85 of Hawthorn Bancshares by Holtaway Jonathan on 6th of February 2025. This event was filed by Hawthorn Bancshares with SEC on 2025-02-06. Statement of changes in beneficial ownership - SEC Form 4  
Hawthorn Bancshares
  few hours ago at Macroaxis
Filed for Holtaway Jonathan
Filed transaction by Zenas BioPharma, Common Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). Acquisition of 25000 common stock at 6.67 of Zenas BioPharma, by Moulder Leon O Jr on 18th of February 2025. This event was filed by Zenas BioPharma, Common with SEC on 2025-02-18. Statement of changes in beneficial ownership - SEC Form 4  
Zenas BioPharma, Common
  few hours ago at Macroaxis
Filed for Moulder Leon O Jr
Filed transaction by Zenas BioPharma, Common Director. Grant, award or other acquisition pursuant to Rule 16b-3(d). Acquisition of 10000 common stock at 7.76 of Zenas BioPharma, by Xiao Ting on 7th of February 2025. This event was filed by Zenas BioPharma, Common with SEC on 2025-02-07. Statement of changes in beneficial ownership - SEC Form 4  
Zenas BioPharma, Common
  few hours ago at Macroaxis
Filed for Xiao Ting
Filed transaction by FB Bancorp, Common Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). Acquisition of 175 common stock at 11.45 of FB Bancorp, by Todd Wanner on 21st of February 2025. This event was filed by FB Bancorp, Common with SEC on 2025-02-21. Statement of changes in beneficial ownership - SEC Form 4  
FB Bancorp, Common
  few hours ago at Macroaxis
Filed for Todd Wanner